Jeongwoo Pharmaceutical

Jeongwoo Pharmaceutical is a South Korean pharmaceutical company specializing in the research, development, and manufacturing of traditional Korean herbal medicines, natural products, and over-the-counter (OTC) drugs. Founded in 1982, the company operates a GMP-certified manufacturing facility in Asan, South Korea, producing a wide range of herbal formulations, health supplements, and OTC medications. Jeongwoo Pharmaceutical is actively modernizing traditional medicine through scientific validation, with its lead pipeline candidate, ChondroT, a multi-target herbal extract for osteoarthritis, currently in Phase 3 clinical trials. The company also collaborates on novel natural product therapeutics, including a Phase 2 candidate for female infertility (PLCR) and preclinical programs for dermatological disorders. In mid-2026, the company entered corporate rehabilitation proceedings to restructure its debt and is currently pursuing a pre-packaged M&A process to secure a new strategic acquirer.